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The Carcinogenicity of Arsenic
by Goran Pershagen*
A carcinogenic role ofinorganic arsenic has been suspected for nearly a century. Exposure to
inorganic arsenic compounds occurs in some occupational groups, e.g., among smelter workers
and workers engaged in the production and use of arsenic containing pesticides. Substantial
exposure can alsoresult fromdrinking water in certain areas andthe use ofsomedrugs. Tobacco
and wine have had high As concentrations due to the use of arsenic containing pesticides.
Inorganic arsenic compounds interfere with DNA repair mechanisms and an increased
frequency ofchromosomal aberrations have been observed amongexposed workers and patients.
Epidemiological data show that inorganic arsenic exposure can cause cancer ofthe lung and
skin. The evidence of an etiologic role of arsenic for angiosarcoma of the liver is highly
suggestive; however, the association between arsenic and cancer of other sites needs further
investigation. No epidemiological data are available on exposure to organic arsenic compounds
and cancer. Animal carcinogenicity studies involving exposure to various inorganic and organic
arsenic compounds by different routes have been negative, with the possible exception of some
preliminary data regarding lung cancer and leukemia. Some studies have indicated an increased
mortality from lung cancer in populations living near point emission sources ofarsenic into the
air. The role of arsenic cannot be evaluated due to lack of exposure data.
Epidemiological data suggest that the present WHO standard for drinking water (50 ,g As/l.)
provides only a small safety margin with regard to skin cancer.
Introduction
Inorganic arsenic has had aclassicreputation as a
poison for centuries. Recent reviews on arsenic
toxicity have associated long-term exposure to
inorganic arsenic compounds with damage to the
respiratory, cardiovascular, nervous, and hemato-
poietic systems, as well as lesions of the skin and
liver (1, 2). Health effects of organic arsenic com-
pounds have not been adequately investigated.
Alreadyin 1888, Hutchinson associated inorganic
arsenic medication with skin cancer (3). Eversince,
numerous reports have linked arsenic exposure to
the development of tumors in various organs. An
intriguing and unique feature has been that no
animal model has been established for arsenic
carcinogenicity, although strong epidemiological
evidence exists to relate exposure to inorganic
arsenic to lung and skin cancer. In 1980, after
reviewing available experimental and epidemiolog-
ical data, IARC concluded that inorganic arsenic
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compounds are skin and lung carcinogens in hu-
mans (4).
In the following, evaluation of dose response
relationships with regard to lung cancer will be
given special attention. Assessment ofcancerrisks
oflow exposure doses is oftenbased onthe assump-
tion of a linear dose-response curve (5, 6). The
experimental and epidemiological evidence for this
assumption is very weak; however, the usage of
this model can be justified as a probably conserva-
tive estimate of the risk. Consequently, the
extrapolations of cancer risks from high to low
doses inthispapershouldberegarded as somewhat
speculative and serve mainly as a basis for further
discussion.
Exposure
Arsenic is ametalloid and is widely distributed in
nature. The processing of some ores and minerals
as well as the production and usage of arsenic
containing pesticides have led to environmental
93pollution. Tobacco contained substantial amounts,
e.g. upto40mg/kgAs, some decades agoduetothe
use of arsenical pesticides in certain countries (7).
Coal contains arsenic, sometimes up to 1500 mg/kg
(8). In the U.S. in 1971, the average content ofcoal
was 5 mg/kg (9). Arsenic particulate is released at
combustion (10, 11). Burning ofwood treated with
arsenic containing preservatives can also resultin a
release of arsenic to air (12).
Water ordinarily contains low levels of arsenic
(< 10 ,ug/l.), dominate inthe inorganic form (13-15).
In certain areas, however, natural concentrations
may reach several hundred micrograms per liter
(16-18). Contamination of water has resulted from
industrial operations and the use of geothermal
energy (19, 20).
Certain foodstuffs contain appreciable amounts
ofarsenic, e.g., some marine fish and crustaceans.
Concentrations may exceed 10 mg As/kg (21, 22).
The major part ofthe arsenic in marine organisms
is present as organic arsenic compounds of high
chemical stability (23). Accumulation of arsenic in
the tissues ofpoultry and swine can result from the
use oforganic arsenic compounds as feed additives
(24, 25). The use of arsenic-containing pesticides
can give rise to increased arsenic levels in wine
(26).
When considering the carcinogenity ofarsenic it
is ofimportance to distinguish between exposure to
inorganic and organic forms ofarsenic. Only expo-
sure to inorganic arsenic compounds have been
associated with cancer. Although data on the con-
tent of inorganic arsenic in various foodstuffs is
limited, an estimation can be made ofthe total daily
intake ofinorganic arsenic based on data on metab-
olism and urinary excretion of various arsenic
species. In individuals not excessively exposed to
arsenic either via food, drinking water, or occupa-
tion, the totaldaily absorption should notexceed 50
,ugofinorganic arsenic (27). Foranaverage smoker
a few micrograms of arsenic may be inhaled. The
high content of arsenic in some tobaccos especially
from the U.S. in the 1950's, may have caused
inhalation of more than 100 ,g of As daily. The
daily arsenic intake in areas with high concentra-
tions of arsenic in water can be several hundred
micrograms (28). Up to 10 mg of inoorganic triva-
lent arsenic could be ingested daily by patients
taking certain drugs (29).
Occupational exposure to inorganic arsenic com-
pounds occurs primarily among smelter workers
and workers engaged in the production and use of
arsenic containingpesticides. Airborne arsenic con-
centrations of several hundred micrograms per
cubic meter have been reported in the workroom
atmosphere (30).
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Epidemiological Studies
Inorganic arsenic compounds have been impli-
cated as human carcinogens, both occupationally
and following the use of arsenic containing drugs.
Ingestion ofarsenic-rich water has been associated
with skin cancerin some areas. The form ofarsenic
in the water was not determined, however. Data
fromotherareas showthatarsenicinwaterprimar-
ily is present in inorganic forms. Epidemiological
studies on carcinogenic effects of organic arsenic
compounds are lacking.
A number ofepidemiological studies have inves-
tigated the role ofoccupational exposure to arsenic
for the development of cancer of the respiratory
tract. With few exceptions these reports do not
lend themselves to discussions of dose-response
relationships, and consequently many reports will
only be discussed briefly here. As a rule the
exposure environment in occupational situations
involving arsenic is very complex, but unfortun-
ately the exposure to other agents, as well as
smoking habits, has only rarely been reported.
An increased lung cancer mortality among work-
ers engaged in the production of insecticides
containing inorganic arsenic compounds has been
observed in three epidemiological studies (31-33).
Ott et al. (32) were able to show a positive
dose-response relationship with estimated degree
of arsenic exposure among workers in a plant
producing lead arsenate and calcium arsenate. The
increase in the lung cancer mortality with increas-
ing dose was, however, consistent only in the
highest exposure categories i.e. those where the
dose exceeded 40 ,ug/m3 as a daily 8 hr time-
weighted average airborne arsenic concentration
during 40 years [exposure categories in original
publication recalculated by Blejer and Wagner (34)
to correspond to exposure during a whole "working
life"].
The spraying of pesticides containing inorganic
arsenic compounds, predominantly of very low
solubility, has alsobeenassociated withlungcancer
among vintners in Germany and France (35, 36).
Unfortunately these reports are only case studies
with some macroepidemiological evidence and can-
not be used for dose-response discussions. A U.S.
study on orchardists spraying lead arsenate failed
to show anincreased cancermortality (37). NIOSH,
however, laterclaimed that anelevated lungcancer
mortality was at hand in this occupational group
(38). Poor or nonexistent data on arsenic exposure
preclude further evaluation of these reports.
Workers involved in copper smelting, where
substantial arsenic exposure can occur, have been
reported to experience an increased risk of dying
Environmental Health Perspectivesfrom lung cancer (39-44). Epidemiological evidence
has come fromJapan, Sweden and the U.S., and as
a rule a positive gradient for lung cancer mortality
with increasing dose ofarsenic has been presented.
Leeand Fraumeni (39) andTokudome and Kuratsune
(40) reported 8- and 12-fold excess lung cancer
mortalities, respectively, in the highest exposure
categories in two cohort studies on smelter work-
ers. Noactual dataonarsenic exposure weregiven.
Axelsson et al. (43) in acase-control study revealed
a relative risk offive for death due to cancer ofthe
lungaswellas apositivedose-response relationship
among Swedish copper smelter workers exposed to
high levels of airborne arsenic. Smoking habits
could not account for this excess mortality (44).
Pinto et al. (41) found a correlation between total
life time exposure to arsenic and excess mortality
from lung cancer in a cohort study among workers
at a U.S. copper smelter. From the data it could be
estimated that exposure to airborne arsenic levels
of around 50 ,ug/m3 for more than 25 years
corresponded to a nearly 3-fold excess mortality in
lung cancer at an age over 65 years. This should be
regarded as a high estimate of the risk as the
assessment of exposure in the study was based on
urinary excretion ofarsenic in various departments
ofthe smelter in 1973, and the exposure during the
relevant time period was, according to the authors,
probably five to ten times higher. Smoking habits
were recorded from a sample ofthe subjects under
study and apparently were not responsible for the
excess mortality (45).
Ambient exposure to airborne arsenic has also
been considered as a possible causative agent for
lung cancer. Four epidemiological studies on popu-
lations living near point emission sources ofarsenic
to air have revealed moderate increases in lung
cancer mortalities (46-49). Data on airborne arsenic
concentrations was only reported in one of the
studies (47) and information on the fraction of the
population and lung cancer cases occupationally
exposed (which would be expected to contribute to
the excess lung cancer mortality) was only given in
two ofthe studies (48, 49). In one ofthese (49) the
excess mortality from lung cancer was no longer
significant when workers employed at a smelter
with high levels of airborne arsenic in some
workplaces were excluded. It is not possible from
the evidence presented to assess the role ofarsenic
in ambient air as a possible contributor to lung
cancer in the community.
Histological classification of the lung cancers
associated with occupational arsenic exposure has
been performed in two of the above mentioned
studies (43, 47). A tendency towards poorly differ-
entiated carcinomas was evident in both reports,
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but this finding needs to be validated before any
definite conclusions can be drawn.
Skdn cancer has been associated with exposure to
arsenic, mainlyviadrugsanddrnkingwater(50-53).
Only two reports lend themselves to discussions of
dose-response relationships. Fierz (52) found a
prevalence of8% ofskin cancer among 262 patients
treated with arsenic forvarious chronicdermatoses.
Arsenic was taken as Fowler's solution in inorganic
trivalent form. An increased prevalence of skin
cancer, predominantly of the multiple basal cell
type, seemedtobe presentamongpatients whohad
ingested a total of 1000 ml or more ofthe solution
(1000 ml corresponds to 7600 mg ofarsenic). In this
group the prevalence was over 20%. The preva-
lence ofpalmo-plantar hyperkeratosis, a character-
istic feature of chronic arsenic poisoning increased
with increasing dose ofarsenic, i.e., from less than
10% in the lowest exposure group to over 90%
amongpatients who had taken more than 9 g ofAs.
Caution must be taken in the interpretation ofthe
results in this study in view ofthe lack ofa control
group and the low response rate. Only 18% of the
total number of patients intended for the study
appeared forphysicalexamination. Tseng(53) found
a positive dose-response relationship between the
content ofarsenic in well water and skin cancerin a
region of Taiwan with high concentrations of arse-
nic in well water. The content ofarsenic in the well
water ranged from 0.01 to 1.82 mg/l., with an
average ofabout 0.5 mg/l. (17). A total of428 cases
of skin cancer was recorded in a population of 40,
421, giving an overall prevalence of about 1%.
Assuming adaily intake of2 liters ofwater, it could
be estimated from the data presented that a total
ingested dose ofarsenic ofabout 20 g corresponded
to aprevalence ofskin cancer ofapproximately 6%.
The increase in prevalence with increasing arsenic
dose was partly due to a higher background preva-
lence ofskin cancer in older age groups, although it
was also evident that this could not explain the
whole increase. Morton et al. (54) found no increase
in incidence of skin cancer in an area in the U.S.
with elevated levels of arsenic in water. As the
concentrations of arsenic in the water were only
moderately increased, ranging from 0.004 to 0.033
mg/I., the absence of a positive finding in this area
does not necessarily contradict the previous data.
The difference in nutritional status between
Taiwanese and U.S. populations might also be of
importance.
The neoplastic changes of the skin associated
with exposure to arsenic are ofseveral types, e.g.,
Bowen's disease, basal and squamous cell carcino-
ma. Bowen's disease, and basal cell carcinomas of
arsenic origin are usually multiple and occur on all
95parts of the body, often on the trunk (52, 53).
Squamous cell carcinomas develop fromthe keratoses
on the extremities. Histologically neither of the
lesions possess any unique features when associated
with arsenic (54, 55).
Angiosarcoma (or hemangioendothelioma) ofthe
liver has been reported following exposure to
arsenic via contaminated wine (57), drinking water
(58), orFowler's solution (59-62). Thetotalingested
dose of arsenic could be estimated to be at least
several grams. Only case reports of this rare
tumour exist; the evidence, however, is highly
suggestive of an etiologic role of arsenic.
Two epidemiological studies on occupational ex-
posure to inorganic arsenic compounds have shown
anincreased mortality from cancer ofthelymphatic
and hematopoietic systems (32, 43). The number of
deaths due tothese causes was smallinboth studies
and the findings have not been confirmed in other
studies on occupational exposure or exposure via
drinking water or drugs.
Experimental Studies
Inorganic arsenic compounds have been tested
for carcinogenicity by various routes of exposure.
In the following the different exposure routes will
be treated separately. Finally investigations on
carcinogenicity of some organic arsenic compounds
will be discussed.
Only two preliminary reports are available on
exposure to inorganic arsenic compounds via the
respiratorytract. Ishinishi(63)gave 15intratracheal
instillations to rats of arsenic trioxide, copper ore
and flue dust. The total arsenic doses ranged
between 1.5 and 3 mg in the groups. One adenocar-
cinoma appeared in the group receiving the flue
dust. When the exposure was combined with
benzo(a)pyrene instillations a tendency towards a
positive, although not statistically significant, in-
teraction on tumour induction appeared. Only be-
tween seven and ten animals in the various groups
survived the 15 instillations. Ivankovic et al. (64)
were able to produce lung tumors in 9 of 15 rats
surviving a single intratracheal instillation of a
mixture of calcium arsenate, copper sulfate and
calcium oxide. The exposure dose to As was 0.07
mg. No lung tumors appeared in a control group
receiving an intratracheal instillation of 0.9% sa-
line. This studyindicates acarcinogenic potential of
the mixture given; however, the role of arsenic
cannot be evaluated in detail.
Several experimental studies have investigated
the carcinogenicity of inorganic trivalent (65-72)
and pentavalent (68, 73, 74) arsenic by oral admin-
istration. Thecompounds tested were arsenictriox-
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ide (65, 67, 70, 72) sodium arsenite (68, 69, 71),
potassium arsenite (66), sodium arsenate (68, 73,
74), and lead arsenate (73, 74). None ofthe studies
provide positive evidence ofarsenic carcinogenicity.
Inorganic arsenic compounds have also been tested
for carcinogenicity by skin application (66, 67,
75-77). Neithertumor-initiatingnortumor-promoting
activities of arsenic could be demonstrated with
arsenic trioxide (76, 77), sodium arsenite (75),
potassiumarsenite (66, 78) orsodium arsenate (67).
An experimental systeminvolving weekly subcu-
taneous injections in mice with sodium arsenate
(corresponding to a total of 10 mg As/kg body
weight) indicated a role of arsenic for the develop-
ment oflymphocytic leukemia and lymphoma both
in treated animals and their offspring (79). The
interpretation of the results in this experiment is
difficult as the control animals were not sham
treated by injection of the vehicle solution and
because some exposed and control animals were
still alive at time of reporting.
Organic arsenic compunds such as carbarsone
(80, 81), arsanilic acid (66, 82) and 3-nitro-4-
hydroxyphenylarsonic acid (83) have been tested
for carcinogenicity. The exposure routes included
peroral administration, skin application or subcuta-
neous injection. All studies were essentially nega-
tive, with the possible exception of one report on
hepatomas in trout fed carbasone (80). This finding
could not be evaluated in detail as the original data
were not available.
Metabolism and Mechanism of
Effects
The metabolism of various arsenic compounds
has recently been reviewed (1, 2). Only data
pertinent to the carcinogenicity ofarsenic, e.g., tn
vitro and in vivo studies on interactions with the
genetic material, will be mentioned here.
Inorganic arsenic compounds may interfere with
DNA repair mechanisms. Incorporation of radio-
actively labelled nucleotides in dermal cells and
lymphocytes was reduced by sodium arsenate (84,
85). Post-replication repair in bacteria was de-
creased by arsenite (86).
One mutagenicity test in vitro was positive for
sodium arsenate, sodium arsenite and arsenic tri-
chloride (87) while another failed to show any
mutagenic response for inorganic trivalent and
pentavalent arsenic (88).
An increased frequency of chromosomal aberra-
tions has been observed among workers exposed to
inorganic arsenic compounds, as well as in patients
who had taken drugs containing arsenic (85, 89).
Chromosomal aberrations have also been produced
Environmental Health Perspectivesin vitro by inorganic arsenic salts (90, 91).
No data are available on interactions of organic
arsenic compounds with DNA.
Inorganic trivalent arsenic can inhibit enzymatic
activity by reaction with the sulfhydryl groups of
proteins (92). Both pentavalent and trivalent arse-
nic can inhibit mitochondrial respiration and uncou-
ple oxidative phosphorylation. It has been sug-
gested that arsenic may replace phosphorus in the
DNA chain (85).
Discussion and Recommendations
for Future Research
A peculiarity with arsenic carcinogenicity is the
discrepancy betweenthefindingsinepidemiological
and experimental animal studies. Only recently
some preliminary animal data indicate a role of
inorganic arsenic for the development of lung
cancer. A reason for the negative findings may be
that insoluble arsenic compounds have not pre-
viously been tested in animal models involving
exposure via the respiratory system. The inability
of eliciting a carcinogenic response with soluble
nickel and chromium compounds is well known,
while compounds of low solubility readily produce
lung cancer. The presence of inorganic arsenic
compounds of low solubility has been indicated in
the workroom air of smelters and the arsenic
pesticides were often insoluble compounds (36, 93).
Recently, data have also appeared indicating a
retention ofarsenic in the lung long after cessation
of occupational exposure (94, 95). Experimental
animal studies on exposure of the respiratory
system to inorganic arsenic compounds of low
solubility are thus greatly needed. There is also a
lack of studies on cocarcinogenicity of arsenic
following exposure of the respiratory tract.
Aparticularretention ofinorganic arsenic in skin
is indicated in both man and animals (96, 97). This
may be explained by its high content of sulfhydryl
groups. Skin cancer has been observed in humans
afterperoral exposure to arsenic and thus occurs in
an indirectly exposed tissue. The effect is then
dependant on processes of absorption, metabolism
and excretion. This implicates that direct skin
application to animals may not be adequate in
producing cancer. The difference in hair growth
and distribution between man and laboratory ani-
mals may also be of importance when animals are
exposed perorally. It can thus be anticipated that
the establishment of an animal model for arsenic
skin carcinogenesis may be difficult.
Exposure to airborne arsenic compounds take
place in many occupational groups. In the U.S., it
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was estimated that approximately 660,000 employ-
eeswereinvolved inthe commercialcycle ofarsenic
in 1978 (98). An even larger number of people are
exposed to increased levels due to tobacco smoking
orbylivinginthe vicinity ofsmelters orotherpoint
emission sources of arsenic. Coal combustion as a
source of arsenic in ambient air should also be
considered. It would be of great importance to
characterize in detail the airborne arsenic com-
pounds in these exposure situations, in order to
make itpossible to assessthecarcinogenic potential
of the various forms of arsenic in future epidemio-
logical investigations.
One of the studies discussed above can be used
for estimations of lung cancer risks from exposure
to arsenic in ambient air, assuming a nonthreshold
linear dose-response relationship. At a recent WHO
Task Group Meetingitwas estimated fromthe data
by Pinto et al. (41) that a 25% excess in lung cancer
incidence would result from lifetime (70 yr) expo-
sure to 1 ,g As/m3 (WHO Environmental Health
Criteria: Arsenic. World Health Organization, Ge-
neva, to be published). It is obvious that this
constitutes only a rough estimate and that the
major determinant of lung cancer, e.g., smoking
habits, also needs to be considered. An ambient
airborne exposure level of 1 ,g/m3 has been re-
ported in some areas around point emissions of
arsenic to air (99-101). As noted above, a few
epidemiological studies have indicated an increased
mortality from lung cancer in populations living in
such areas, however, the lack of exposure data in
these studies precludes an evaluation ofthe role of
arsenic. Further surveillance ofthe cancer morbid-
ity in areas with high concentrations of airborne
arsenic is needed.
In reports relating arsenic exposure via drugs
anddrnkingwaterto cancerofthe skin (52, 53) itis
indicated that ingestion ofseveral grams ofarsenic
increases the prevalence of skin cancer. The pres-
entWHO drinkingwater standard of0.05 mgAs/l.,
which would lead to a total ingestion of about 2 g
during 50 yr (2 liters water/day), does not give a
large safety margin. It was estimated by the WHO
Task Group on Arsenic that the lifetime (70 yr) risk
ofskin cancer from arsenic in drinkingwater would
be 25% permgAs/l. ofwater (WHO, loc. cit.). This
would correspond to about a 1% risk ofskin cancer
at the present WHO drinking water standard. As
skin cancer following peroral exposure to arsenic
occurs in an indirectly exposed tissue, the assump-
tion of a nonthreshold linear dose-response rela-
tionship may not be appropriate. There is a great
need for further data on the occurrence of skin
cancer in populations exposed to arsenic.
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